Oncoustics Inc. combines their proprietary AI with low-cost, point-of-care ultrasound devices to produce a portable medical diagnostic and monitoring system for healthcare providers. Their primary product detects liver disease, enabling preventive care and early intervention. Their new ‘Lung product’ will enable on-site diagnosis of pneumonia (a symptom of severe COVID-19 infection) without the need for X-Ray imaging.